Literature DB >> 29662355

Role of salsolinol in the regulation of pituitary prolactin and peripheral dopamine release.

Márk Oláh1, Ibolya Bodnár1, Galit Daniel1, Béla E Tóth1,2, Miklós Vecsernyés3, György M Nagy1.   

Abstract

(R)-Salsolinol (SAL), a dopamine (DA)-related tetrahydroisoquinoline, has been found in extracts of the neuro-intermediate lobes (NIL) of pituitary glands and in the median eminence of the hypothalamus obtained from intact male rats and from ovariectomized and lactating female rats. Moreover, analysis of SAL concentrations in NIL revealed parallel increases with plasma prolactin (PRL) in lactating rats exposed to a brief (10 min) suckling stimulus after 4-h separation. SAL is sufficiently potent in vivo to account for the massive discharge of PRL that occurs after physiological stimuli (i.e. suckling). At the same time, it was without effect on the secretion of other pituitary hormones. It has been also shown that another isoquinoline derivative, 1-methyldihydroisoquinoline (1MeDIQ), which is a structural analogue of SAL, can dose-dependently inhibit the in-vivo PRL-releasing effect of SAL. Moreover, 1MeDIQ can inhibit the elevation of plasma PRL induced by physiological stimuli, for example suckling, or in different stressful situations also. 1MeDIQ also has a psycho-stimulant action, which is fairly similar to the effect of amphetamine, i.e. it induces an increase in plasma catecholamine concentrations. It is clear from these data that this newly discovered endogenous compound could be involved in regulation of pituitary PRL secretion. It has also been observed that SAL is present in peripheral, sympathetically innervated organs, for example the atrium, spleen, liver, ovaries, vas deferens, and salivary gland. Furthermore, SAL treatment of rats results in dose-dependent and time-dependent depletion of the DA content of the organs listed above without having any effect on the concentration of norepinephrine. More importantly, this effect of SAL can be completely prevented by amphetamine and by 1MeDIQ pretreatment. It is clear there is a mutual interaction between SAL, 1MeDIQ, and amphetamine or alcohol, not only on PRL release; their interaction with catecholamine "synthesis/metabolism" of sympathetic nerve terminals is also obvious.

Entities:  

Keywords:  Alcohol; Amphetamine; Peripheral dopamine; Prolactin; Salsolinol

Year:  2011        PMID: 29662355      PMCID: PMC5893001          DOI: 10.1007/s12522-011-0086-5

Source DB:  PubMed          Journal:  Reprod Med Biol        ISSN: 1445-5781


  66 in total

1.  Effect of posterior pituitary denervation (PPD) on prolactin (PRL) and alpha-melanocyte-stimulating hormone (alpha-MSH) secretion of lactating rats.

Authors:  M Vecsernyés; K Krempels; B E Tóth; J Julesz; G B Makara; G M Nagy
Journal:  Brain Res Bull       Date:  1997       Impact factor: 4.077

2.  Characteristics of prolactin-releasing response to salsolinol in vivo in cattle.

Authors:  T Hashizume; T Sawada; T Yaegashi; H Saito; A Ezzat Ahmed; Y Goto; Y Nakajima; J Jin; E Kasuya; G M Nagy
Journal:  Domest Anim Endocrinol       Date:  2010-02-02       Impact factor: 2.290

Review 3.  [Alcoholic effect on male sexual function].

Authors:  N Taniguchi; S Kaneko
Journal:  Nihon Rinsho       Date:  1997-11

4.  Salsolinol induces a decrease in cyclic AMP at the median eminence and an increase at the adenohypophysis in lactating rats.

Authors:  Balázs Radnai; Zoltán Kandár; Anikó Somogyvári-Vigh; Zsuzsanna Mergl; Márk Oláh; Ferenc Fülöp; Miklós Vecsernyés; György M Nagy
Journal:  Brain Res Bull       Date:  2004-12-14       Impact factor: 4.077

Review 5.  Hyperprolactinemia following chronic alcohol administration.

Authors:  Dipak K Sarkar
Journal:  Front Horm Res       Date:  2010-07-05       Impact factor: 2.606

Review 6.  Hormonal control of the surfactant system in fetal lung.

Authors:  C R Mendelson; V Boggaram
Journal:  Annu Rev Physiol       Date:  1991       Impact factor: 19.318

Review 7.  Amine-related neurotoxins in Parkinson's disease: past, present, and future.

Authors:  Toshiharu Nagatsu
Journal:  Neurotoxicol Teratol       Date:  2002 Sep-Oct       Impact factor: 3.763

8.  Alkaloids from catecholamines in adrenal tissue: possible role in alcoholism.

Authors:  G Cohen; M Collins
Journal:  Science       Date:  1970-03-27       Impact factor: 47.728

9.  Sex-related difference in the release of dopamine into hypophysial portal blood.

Authors:  G A Gudelsky; J C Porter
Journal:  Endocrinology       Date:  1981-11       Impact factor: 4.736

Review 10.  Dopamine-derived salsolinol derivatives as endogenous monoamine oxidase inhibitors: occurrence, metabolism and function in human brains.

Authors:  Makoto Naoi; Wakako Maruyama; Georgy M Nagy
Journal:  Neurotoxicology       Date:  2004-01       Impact factor: 4.294

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.